DK1178824T3 - Staphylococcus aureus-antigenholdig helcellevaccine - Google Patents
Staphylococcus aureus-antigenholdig helcellevaccineInfo
- Publication number
- DK1178824T3 DK1178824T3 DK00932194T DK00932194T DK1178824T3 DK 1178824 T3 DK1178824 T3 DK 1178824T3 DK 00932194 T DK00932194 T DK 00932194T DK 00932194 T DK00932194 T DK 00932194T DK 1178824 T3 DK1178824 T3 DK 1178824T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- aureus
- type
- whole cell
- cell vaccine
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/307,775 US6294177B1 (en) | 1996-09-11 | 1999-05-10 | Staphylococcus aureus antigen-containing whole cell vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1178824T3 true DK1178824T3 (da) | 2006-10-09 |
Family
ID=23191126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00932194T DK1178824T3 (da) | 1999-05-10 | 2000-05-10 | Staphylococcus aureus-antigenholdig helcellevaccine |
Country Status (15)
Country | Link |
---|---|
US (2) | US6294177B1 (da) |
EP (1) | EP1178824B1 (da) |
JP (1) | JP2002544169A (da) |
AT (1) | ATE337015T1 (da) |
AU (1) | AU777218B2 (da) |
BR (1) | BR0010478A (da) |
CA (1) | CA2372633C (da) |
CY (1) | CY1105744T1 (da) |
DE (1) | DE60030274T2 (da) |
DK (1) | DK1178824T3 (da) |
ES (1) | ES2270835T3 (da) |
MX (1) | MXPA01011507A (da) |
NZ (1) | NZ515394A (da) |
PT (1) | PT1178824E (da) |
WO (1) | WO2000067785A2 (da) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610293B1 (en) * | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US6936258B1 (en) * | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
US6974573B2 (en) * | 1999-11-01 | 2005-12-13 | Mucovax Holdings, B.V. | Antibody production in farm animals |
US20030096315A1 (en) | 2000-05-03 | 2003-05-22 | Sanders Mitchell C. | Device for detecting bacterial contamination and method of use |
JP4424984B2 (ja) * | 2001-06-15 | 2010-03-03 | インヒビテックス インコーポレーテッド | コアグラーゼ陰性ブドウ球菌および黄色ブドウ球菌由来の表面蛋白質を認識する、交差反応性モノクローナルおよびポリクローナル抗体 |
CA2474458A1 (en) * | 2002-01-31 | 2003-08-07 | Mitchell C. Sanders | Method for detecting microorganisms |
KR100965026B1 (ko) * | 2002-02-13 | 2010-06-21 | 이뮤놀로지 래보러토리스 인코포레이티드 | 미생물 감염증을 치료하기 위한 조성물 및 방법 |
US6984381B2 (en) | 2002-07-05 | 2006-01-10 | The United States Of America As Represented By The Secretary Of Agriculture | Vaccine for the prevention of bacterial infection of the bovine mammary gland |
WO2004043405A2 (en) * | 2002-11-12 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
CN102657855B (zh) | 2004-09-22 | 2015-12-09 | 葛兰素史密丝克莱恩生物有限公司 | 用于进行抗葡萄球菌接种的免疫原性组合物 |
MX2007008358A (es) * | 2005-01-10 | 2007-09-06 | Nabi Biopharmaceuticals | Metodo para tratar la infeccion con staphylococcus aureus. |
US20060228368A1 (en) * | 2005-04-07 | 2006-10-12 | Nabi Biopharmaceuticals | Method of protecting against staphylococcal infection |
JP5096326B2 (ja) | 2005-06-13 | 2012-12-12 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ブドウ球菌感染を治療および予防するためのPanton−Valentineロイコシジンの使用 |
NZ570805A (en) * | 2006-03-30 | 2011-10-28 | Glaxosmithkline Biolog Sa | Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus |
TW200744632A (en) | 2006-06-12 | 2007-12-16 | Nabi Biopharmaceuticals | Use of alpha-toxin for treating and preventing staphylococcus infections |
US20080170996A1 (en) * | 2006-07-28 | 2008-07-17 | The Board Of Regents Of The University Of Texas System | Compositions and Methods for Stimulation of Lung Innate Immunity |
WO2008146830A1 (ja) * | 2007-05-28 | 2008-12-04 | The Kitasato Institute | パラ百日咳菌全菌体ワクチン組成物 |
JP5249326B2 (ja) * | 2007-07-23 | 2013-07-31 | ワクチン リサーチ インターナショナル ピーエルシー | 不活化ブドウ球菌全細胞ワクチン |
US8840906B2 (en) * | 2007-08-31 | 2014-09-23 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung disease and conditions |
US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
KR101785373B1 (ko) * | 2008-07-21 | 2017-10-16 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물 |
US8758765B2 (en) * | 2008-07-29 | 2014-06-24 | The University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
WO2010030790A2 (en) * | 2008-09-10 | 2010-03-18 | The Texas A&M University System | Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
WO2010042481A1 (en) | 2008-10-06 | 2010-04-15 | University Of Chicago | Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
US20100150942A1 (en) * | 2008-12-03 | 2010-06-17 | Cantor Thomas L | Affinity purified human polyclonal antibodies and methods of making and using them |
MX2011010050A (es) | 2009-03-25 | 2011-12-14 | Univ Texas | Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos. |
PL2414387T3 (pl) | 2009-04-03 | 2016-06-30 | Univ Chicago | Kompozycje i sposoby związane z wariantami białka A (SpA) |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
DK2493498T3 (da) | 2009-10-30 | 2017-05-08 | Glaxosmithkline Biologicals Sa | Oprensning af Staphylococcus aureus type 5- og type 8 kapselsaccharider |
JP2013523818A (ja) | 2010-04-05 | 2013-06-17 | ザ・ユニバーシティー・オブ・シカゴ | 免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法 |
KR20130093084A (ko) | 2010-07-02 | 2013-08-21 | 더 유니버시티 오브 시카고 | 단백질 A(SpA) 변이체와 관련된 조성물 및 방법 |
US9095540B2 (en) | 2010-09-09 | 2015-08-04 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens |
US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
BR112014026861A2 (pt) | 2012-04-26 | 2018-05-15 | Univ Chicago | antígenos de estafilococos coagulase e métodos de seu uso |
GB201310008D0 (en) | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
WO2016044839A2 (en) | 2014-09-19 | 2016-03-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds |
AU2015359503B2 (en) | 2014-12-10 | 2019-05-09 | Glaxosmithkline Biologicals Sa | Method of treatment |
US11053532B2 (en) | 2017-04-19 | 2021-07-06 | CAP Diagnostics, LLC | Methods for treating polymicrobial infections |
WO2019055620A1 (en) * | 2017-09-13 | 2019-03-21 | Stc. Unm | SILICIFIED CELL REPLICAS, METHODS OF MANUFACTURE, AND METHODS OF USE |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3345864A1 (de) | 1983-12-19 | 1985-06-27 | Egbert Frh. von 8000 München Malsen-Ponickau | Impfstoff und verfahren zu seiner herstellung |
IN164864B (da) | 1985-05-13 | 1989-06-24 | Commw Scient Ind Res Org | |
US5571511A (en) * | 1990-10-22 | 1996-11-05 | The U.S. Government | Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
US5770208A (en) * | 1996-09-11 | 1998-06-23 | Nabi | Staphylococcus aureus B-linked hexosamine antigen |
US6936258B1 (en) | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
-
1999
- 1999-05-10 US US09/307,775 patent/US6294177B1/en not_active Expired - Lifetime
-
2000
- 2000-05-10 CA CA2372633A patent/CA2372633C/en not_active Expired - Fee Related
- 2000-05-10 BR BR0010478-7A patent/BR0010478A/pt active Search and Examination
- 2000-05-10 WO PCT/US2000/012589 patent/WO2000067785A2/en active IP Right Grant
- 2000-05-10 MX MXPA01011507A patent/MXPA01011507A/es active IP Right Grant
- 2000-05-10 AT AT00932194T patent/ATE337015T1/de active
- 2000-05-10 PT PT00932194T patent/PT1178824E/pt unknown
- 2000-05-10 DE DE60030274T patent/DE60030274T2/de not_active Expired - Lifetime
- 2000-05-10 JP JP2000616810A patent/JP2002544169A/ja active Pending
- 2000-05-10 EP EP00932194A patent/EP1178824B1/en not_active Expired - Lifetime
- 2000-05-10 AU AU49950/00A patent/AU777218B2/en not_active Ceased
- 2000-05-10 NZ NZ515394A patent/NZ515394A/en not_active IP Right Cessation
- 2000-05-10 DK DK00932194T patent/DK1178824T3/da active
- 2000-05-10 ES ES00932194T patent/ES2270835T3/es not_active Expired - Lifetime
-
2001
- 2001-09-24 US US09/961,110 patent/US6537559B2/en not_active Expired - Fee Related
-
2006
- 2006-11-01 CY CY20061101563T patent/CY1105744T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2372633A1 (en) | 2000-11-16 |
DE60030274D1 (de) | 2006-10-05 |
AU4995000A (en) | 2000-11-21 |
DE60030274T2 (de) | 2008-01-10 |
EP1178824B1 (en) | 2006-08-23 |
CA2372633C (en) | 2010-03-30 |
BR0010478A (pt) | 2002-05-21 |
EP1178824A2 (en) | 2002-02-13 |
US20020031528A1 (en) | 2002-03-14 |
US6537559B2 (en) | 2003-03-25 |
NZ515394A (en) | 2004-11-26 |
WO2000067785A3 (en) | 2001-02-08 |
AU777218B2 (en) | 2004-10-07 |
US6294177B1 (en) | 2001-09-25 |
JP2002544169A (ja) | 2002-12-24 |
MXPA01011507A (es) | 2002-11-07 |
ATE337015T1 (de) | 2006-09-15 |
WO2000067785A2 (en) | 2000-11-16 |
PT1178824E (pt) | 2007-01-31 |
CY1105744T1 (el) | 2010-12-22 |
ES2270835T3 (es) | 2007-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1178824T3 (da) | Staphylococcus aureus-antigenholdig helcellevaccine | |
DK0925073T3 (da) | Staphylococcus aureus antigen | |
DE60026691D1 (de) | Staphylococcus-antigene und impstoff | |
BRPI9912227A (pt) | método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método. | |
CA2333732A1 (en) | Redox reversible imidazole-osmium complex conjugates | |
BR0005106A (pt) | Engate para acoplar um implemento a um veìculo utilitário | |
CY1109437T1 (el) | ΣΥΝΘΕΣΕΙΣ β-ΓΛΥΚΑΝΩΝ ΚΑΙ ΕΙΔΙΚΩΝ ΑΝΟΣΟΣΦΑΙΡΙΝΩΝ | |
DK1053256T3 (da) | Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf | |
AU3202195A (en) | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype | |
PT799058E (pt) | Melhoramentos na funcao endometrica ou com ela relacionados | |
AU6303490A (en) | Novel hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents | |
ATE69891T1 (de) | Monoklonalantikoerperabfassung fuer diagnostischen gebrauch. | |
ES557292A0 (es) | Procedimiento para la preparacion de un componente activo inmovilizado destinado al diagnostico. | |
ATE44621T1 (de) | Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung. | |
IT7922818A0 (it) | Procedimento per mantenere attiva la cultura di fermenti. | |
FI881122A (fi) | Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista | |
CA2141025A1 (en) | Anti-mucus glycoprotein monoclonal antibody | |
NO20022276L (no) | Placental human neurokinin-B-forlöper | |
SU694157A1 (ru) | Лабораторный инкубатор | |
HUP0200345A2 (hu) | Új nukleinsav-transzferáló ágensek, ezeket tartalmazó készítmények és alkalmazásuk | |
RU98123923A (ru) | Штамм гибридных культивируемых клеток животных mus musculus l., используемый для получения моноклональных антител к chlamydia | |
UA43662A (uk) | Спосіб оцінки пошкоджень моноцитів та альвеолярних макрофагів | |
SE9203159D0 (sv) | Partikel suspension |